Scientists Pinpoint Location of Plaque Ruptures..

Scientists pinpoint location of plaque ruptures, and a protein that predicts them (FierceBio) Scientists have uncovered new details...

Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...

Completion of Enrollment Remains on Track for Q1, 2024 "While we recently had fireworks, we could be looking at...

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD. Company raises $1.3M USD convertible note...

Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.

Hepion Pharmaceuticals (HEPA) to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences
Pressure Bioscience, Biotech Stock Review, Roland Rick Perry

Pressure Bioscience (PBIO) Meets Ohio State University. Pressure Testing on Food and Beverages.

OHIO STATE INSTALLS, COMMISSIONS NEW PILOT-SCALE ULTRA-SHEAR TECHNOLOGY EQUIPMENT FOR LIQUID FOODS AND BEVERAGES PROCESSING Past News From Ohio...

Adding Pressure BioSciences (PBIO) $0.80 to Watch List.

Long Time Coming, Pressure Bio Reaches Turning Point. Science Finally Meets Revenues. Photo Ric Schumacher CEO

CEO Interview: Ric Schumacher Pressure Bioscience (PBIO).

https://youtu.be/a8d1bawmMQk RELATED: Adding Pressure BioSciences (PBIO) $0.80 to Watch...
pRESSURE bIOSCIENCE

Pressure BioSciences (PBIO) Receives $1.5M Contract for UltraShear Nanoemulsified CBD.

CBD Supply MD, a Leading Maryland-Based CBD Retailer, to Introduce PBIO's UltraShear Processed, Best-in-Class Nanoemulsified CBD Products Across the Multi-State Mid-Atlantic Region

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...

Latest article

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

Major Mpox Outbreak in the Democratic Republic of Congo.

As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

Mpox Infections Rise to Almost Double Last Year’s Numbers.

The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...